This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on vitro and in vivo systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease.
Key Features
Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease
Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease
Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function
Proposes a hypothesis of adenosine A2A receptor function in the striatum
Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints
Do you like dragons? If so, check out this collection of book ones in six series that feature dragons as a primary or secondary character. Find a new series (or multiple series) to dive into with this urban fantasy dragon starter pack. --- Air Bound A normal person, or an elven heiress? Aella thinks she’s leading a normal life in LA, making ends meet. Until she finds something...
Supports Lendle with Commissions Earned